You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《瑞通窩輪》【瑞通認股證牛熊證】恆指兩萬六徘徊、資金即市好淡分歧 騰訊曾跌穿460元、投資者趁低撈好倉 恆指牛53107 熊53064/ 騰訊購17828 沽22278/ 阿裏購28667 沽11799
恆指上週五收報25961點,跌354點(或1.4%),盤中低見25636點。恆指七月累挫近一成,科指累瀉16.8%。今早先升後回,26000點得而復失。恆指好倉(牛證及認購權證)上週五淨流入逾700萬港元(下同),恆指淡倉(熊證及認沽權證)同日淨流出逾3000萬元,反映投資者看好港股將反彈。上週五恆指牛證街貨重貨區爲收回價24700至24799點,而熊證街貨重貨區爲收回價27100至27199點。

工信部提出強化大型互聯網企業責任擔當,加強重要數據安全風險評估,加上券商料內地互聯網監管風險短期持續,大型科企再度受壓。另外,中國恆大(03333)向騰訊(00700)等出售恆騰網絡(00136)股份。騰訊上週五曾挫5.5%,低見465元,其後跌幅逐步收窄,收報479元,跌2.6%。今早再跌近4%,曾失460元。上週五分別有近500萬元和逾100萬元淨流出其輪證好倉和淡倉。

阿裏巴巴(09988)明日公佈截至今年6月底止2022財年首財季業績,券商料集團非公認會計準則淨利潤按年下跌7.6%至上升6.9%,並關注管理層在反壟斷政策下的最新營運指引。另據報阿裏巴巴即將全面接管蘇寧易購。阿裏巴巴上週五收報189元,下挫4.2%,盤中低見185.6元。今早好淡爭持,受阻於190元。分別有逾900萬元和逾130萬元在上週五淨流入其輪證好倉和淡倉。

藥明生物(02269)上週五錄逾6.4億元北水淨賣出,股價收挫4.9%,報118.5元,盤中低見115.1元。今早續跌逾2%,下試115元。早前大股東以每股129元減持的配售價將是重大反彈阻力。輪證資金流方面,逾340萬元淨流入其好倉,淡倉則有逾40萬元淨流出。

調查機構IDC報告指,上季全球智能手機出貨量按年增長13.2%至3.13億臺,其中三星出貨量升9.3%至5900萬臺,排全球第一。手機設備股舜宇光學(02382)上週五低見224元後獲承接,全日跌幅收窄至0.4%,收235.2元,10天和20天線失而復得。今早好淡爭持,於240元之下水平徘徊。上週五逾1100萬元淨流入其輪證好倉,淡倉亦有逾290萬元淨流入。

瑞通相關認股證之選擇:

恆指輕微價外、中短期購17810,行使價:28600點,2021年12月到期,實際槓桿:13.3倍

恆指貼價、中短期沽17845,行使價:25100點,2021年11月到期,實際槓桿:9.2倍

騰訊輕微價外、中年期購17828,行使價:534.3元,2022年4月到期,實際槓桿:5.4倍

騰訊價外、中年期沽22278,行使價:390元,2022年2月到期,實際槓桿:4.8倍

阿裏輕微價外、中短期購28667,行使價:218.88元,2021年12月到期,實際槓桿:7倍

阿裏輕微價外、中短期沽11799,行使價:173.88元,2021年12月到期,實際槓桿:4.8倍

藥明價外、中短期購18757,行使價:150.08元,2021年12月到期,實際槓桿:5倍

舜光價外、中短期購16005,行使價:288.88元,2022年1月到期,實際槓桿:4.3倍

舜光輕微價外、中短期沽16006,行使價:202.88元,2021年12月到期,實際槓桿:4.1倍

小鵬價外、中短期購17080,行使價:198.88元,2022年1月到期,實際槓桿:3.7倍

比迪輕微價外、中短期購16418,行使價:288.88元,2021年12月到期,實際槓桿:4.1倍

比迪輕微價外、中短期沽16906,行使價:220.68元,2021年12月到期,實際槓桿:3.4倍

友邦輕微價外、中年期購15163,行使價:99.99元,2022年3月到期,實際槓桿:6.5倍

友邦輕微價外、中短期沽20597,行使價:80.93元,2021年12月到期,實際槓桿:8.3倍

瑞通相關牛熊證之選擇:

恆指牛證53107,收回價:25473點,槓桿比率:49.3倍,兌換比率12500:1

恆指熊證53064,收回價:26700點,槓桿比率:32倍,兌換比率10000:1

騰訊牛證53112,收回價:425.08元,槓桿比率:9.6倍

騰訊熊證51970,收回價:495元,槓桿比率:12.2倍

阿裏牛證53113,收回價:178.88元,槓桿比率:12.2倍

阿裏熊證51083,收回價:206.88元,槓桿比率:8.1倍

藥明牛證53116,收回價:105.08元,槓桿比率:7.8倍

藥明熊證68061,收回價:149.5元,槓桿比率:3倍

舜光牛證52982,收回價:198元,槓桿比率:5.4倍

舜光熊證68580,收回價:275元,槓桿比率:4.7倍

比迪牛證50215,收回價:190.08元,槓桿比率:3.3倍

比迪熊證52164,收回價:278元,槓桿比率:7.4倍

友邦牛證54110,收回價:84元,槓桿比率:9.8倍

友邦熊證51066,收回價:99.5元,槓桿比率:10.3倍

重要風險通知

本結構性產品並無抵押品。

結構性產品之價格一般可急升亦可急跌,有可能損失結構性產品之全部或重大部分購買價,閣下對此應有所準備。

閣下投資前應瞭解產品風險,如有需要應諮詢專業建議。~

重要聲明:

以上資訊由第三方提供,AASTOCKS.com Limited對於任何包含於、經由、連結、下載或從任何與本網站有關服務所獲得之資訊、內容或廣告,不聲明或保證其內容之正確性或可靠性。對於您透過本網站上之廣告、資訊或要約而展示、購買或取得之任何產品、資訊資料,本公司亦不負品質保證之責任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account